Misoprostol modulates cytokine expression through a cAMP pathway : Potential therapeutic implication for liver disease

Copyright © 2015 Elsevier Inc. All rights reserved.

Détails bibliographiques
Publié dans:Clinical immunology (Orlando, Fla.). - 1999. - 161(2015), 2 vom: 15. Dez., Seite 291-9
Auteur principal: Gobejishvili, Leila (Auteur)
Autres auteurs: Ghare, Smita, Khan, Rehan, Cambon, Alexander, Barker, David F, Barve, Shirish, McClain, Craig, Hill, Daniell
Format: Article en ligne
Langue:English
Publié: 2015
Accès à la collection:Clinical immunology (Orlando, Fla.)
Sujets:Journal Article Randomized Controlled Trial Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S. CREB ChIP Inflammation Liver disease NFκB cAMP plus... Anti-Ulcer Agents Cytokines Lipopolysaccharides Tumor Necrosis Factor-alpha Misoprostol 0E43V0BB57 Interleukin-10 130068-27-8 Cyclic AMP E0399OZS9N